{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:22:06Z","timestamp":1787995326221,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1053\/j.sult.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T01:38:35Z","timestamp":1598751515000},"page":"184-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple Myeloma: Role of Imaging in Diagnosis, Staging, and Treatment Response Assessment"],"prefix":"10.1053","volume":"42","author":[{"given":"Sameh","family":"Nassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Spear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Madewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Mujtaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.sult.2020.08.019_bib0001","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.sult.2020.08.019_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2014.06.087","article-title":"Prognostic significance of quantifying circulating plasma cells in multiple myeloma","volume":"14","author":"Gonsalves","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.sult.2020.08.019_bib0003","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group","volume":"121","author":"Kyle","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.sult.2020.08.019_bib0004","first-page":"2047","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma. (Mayo Clinic Proceedings) (Author Abstract)","volume":"289","author":"Kyle","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.sult.2020.08.019_bib0005","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0006","first-page":"81","article-title":"Family history of hematologic malignancies and risk of multiple myeloma: Differences by race and clinical features","volume":"27","author":"VanValkenburg","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.sult.2020.08.019_bib0007","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8588(18)30341-1","article-title":"The epidemiology of multiple myeloma","volume":"6","author":"Riedel","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.sult.2020.08.019_bib0009","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","article-title":"Patterns of hematologic malignancies and solid tumors among 37,838 first\u2010degree relatives of 13,896 patients with multiple myeloma in Sweden","volume":"125","author":"Kristinsson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1053\/j.sult.2020.08.019_bib0010","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: Spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.sult.2020.08.019_bib0011","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2020.08.019_bib0012","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/leu.2013.86","article-title":"Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma","volume":"27","author":"Rajkumar","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.sult.2020.08.019_bib0013","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: Pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann Oncol"},{"issue":"8 suppl","key":"10.1053\/j.sult.2020.08.019_bib0014","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1557::AID-CNCR5>3.0.CO;2-H","article-title":"Mechanisms of bone lesions in multiple myeloma and lymphoma","volume":"80","author":"Roodman","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/j.sult.2020.08.019_bib0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.clml.2013.06.001","article-title":"Prevalence of iron overload vs iron deficiency in multiple myeloma: Resembling or different from MDS\u2014and stem cell transplant (SCT)\u2014patients?","volume":"13","author":"K\u00f6nig","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.sult.2020.08.019_bib0016","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/leu.2008.131","article-title":"Pathogenesis and treatment of renal failure in multiple myeloma","volume":"22","author":"Dimopoulos","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.sult.2020.08.019_bib0017","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.ackd.2012.04.009","article-title":"The pathogenesis of acute kidney impairment in patients with multiple myeloma","volume":"19","author":"Batuman","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.sult.2020.08.019_bib0018","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0019","doi-asserted-by":"crossref","unstructured":"Brian GM, Durie Md DE. Salmon Md S. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842-54, 1975.","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"10.1053\/j.sult.2020.08.019_bib0020","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0021","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"International staging system for multiple myeloma","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.sult.2020.08.019_bib0023","series-title":"International Myeloma Working Group Consensus Statement and Guidelines Regarding the Current Role of Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma","first-page":"1545","author":"Dimopoulos","year":"2009"},{"key":"10.1053\/j.sult.2020.08.019_bib0024","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0029-1220883","article-title":"Whole-body imaging of bone marrow","volume":"13","author":"Schmidt","year":"2009","journal-title":"Semin Musculoskelet Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/rg.301095066","article-title":"Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET\/CT","volume":"30","author":"Hanrahan","year":"2010","journal-title":"Radiographics"},{"key":"10.1053\/j.sult.2020.08.019_bib0027","series-title":"Imaging Techniques Used in the Diagnosis, Staging, and Follow-Up of Patients With Myeloma","first-page":"716","author":"Mulligan","year":"2005"},{"key":"10.1053\/j.sult.2020.08.019_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","article-title":"Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: An alternative to conventional radiography","volume":"54","author":"Horger","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","article-title":"Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)","volume":"38","author":"Gleeson","year":"2009","journal-title":"Skelet Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00330-007-0738-3","article-title":"Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma","volume":"18","author":"Kr\u00f6pil","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0031","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European Myeloma Network Guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.sult.2020.08.019_bib0032","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinimag.2006.08.018","article-title":"Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey","volume":"30","author":"Ghanem","year":"2006","journal-title":"Clin Imaging"},{"key":"10.1053\/j.sult.2020.08.019_bib0033","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications","volume":"25","author":"Walker","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0034","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.sult.2020.08.019_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1148\/radiol.2522081756","article-title":"Multiple myeloma and monoclonal gammopathy of undetermined significance: Importance of whole-body versus spinal MR imaging","volume":"252","author":"B\u00e4uerle","year":"2009","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2020.08.019_bib0036","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejrad.2007.10.025","article-title":"Whole-body MRI of multiple myeloma: Comparison of different MRI sequences in assessment of different growth patterns","volume":"69","author":"Weininger","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0037","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiology.182.3.1535904","article-title":"Multiple myeloma: Appearance at MR imaging","volume":"182","author":"Libshitz","year":"1992","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2020.08.019_bib0038","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.1995.13.1.251","article-title":"Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma","volume":"13","author":"Moulopoulos","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0039","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdi362","article-title":"Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma","volume":"16","author":"Moulopoulos","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/028418600750063578","article-title":"Imaging of myeloma bone disease\u2014Implications for staging, prognosis and follow-up","volume":"39","author":"Dimopoulos","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0041","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1148\/radiology.209.3.9844655","article-title":"Stage III multiple myeloma: Clinical and prognostic value of spinal bone marrow MR imaging","volume":"209","author":"Lecouvet","year":"1998","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2020.08.019_bib0042","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ajh.23258","article-title":"Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients","volume":"87","author":"Moulopoulos","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1053\/j.sult.2020.08.019_bib0043","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0044","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of magnetic resonance imaging in the management of patients with multiple myeloma: A consensus statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: Diagnosis and treatment","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.sult.2020.08.019_bib0046","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2009.25.5356","article-title":"Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma","volume":"28","author":"Hillengass","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0047","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/leu.2014.75","article-title":"Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma","volume":"28","author":"Merz","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.sult.2020.08.019_bib0048","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.sult.2020.08.019_bib0049","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1182\/blood.V124.21.3359.3359","article-title":"Prospective evaluation of MRI and PET-CT at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial","volume":"124","author":"Moreau","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e31818f45ac","article-title":"Value of precise localization of recurrent multiple myeloma with F-18 FDG PET\/CT","volume":"34","author":"Cholewinski","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.sult.2020.08.019_bib0051","first-page":"1457","article-title":"Whole-body (18)F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.sult.2020.08.019_bib0052","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.sult.2020.08.019_bib0053","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","article-title":"Value of 18F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma","volume":"38","author":"Haznedar","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.sult.2020.08.019_bib0054","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: A consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.sult.2020.08.019_bib0055","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1038\/bcj.2015.87","article-title":"Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: Identification of patients needing therapy","volume":"5","author":"Siontis","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.sult.2020.08.019_bib0056","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130464","article-title":"Clinical and research applications of simultaneous positron emission tomography and MRI","volume":"87","author":"Fraioli","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1053\/j.sult.2020.08.019_bib0057","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2020.08.019_bib0058","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1300439","article-title":"Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma","volume":"369","author":"Mateos","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.sult.2020.08.019_bib0059","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.blre.2013.04.001","article-title":"Management of older adults with multiple myeloma","volume":"27","author":"Palumbo","year":"2013","journal-title":"Blood Rev"},{"key":"10.1053\/j.sult.2020.08.019_bib0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: Changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2013","journal-title":"Leukemia"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217120301074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217120301074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:24:26Z","timestamp":1760135066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217120301074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0887217120301074"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2020.08.019","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Myeloma: Role of Imaging in Diagnosis, Staging, and Treatment Response Assessment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}